Latest Articles

Publication Date
Probiotic supplementation improves quality of life and modulates oestradiol in women with endometriosis: a randomised double-blind pilot trial.

Endometriosis is a chronic, oestrogen-dependent inflammatory disorder affecting up to 10% of reproductive-age women, associated with pelvic pain, infertility, and reduced quality of life. Emerging evidence implicates the vaginal microbiome …

Published: March 27, 2026, midnight
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - digitalmore.co

Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis digitalmore.co

Published: March 25, 2026, 12:42 a.m.
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - The Manila Times

Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis The Manila Times

Published: March 25, 2026, 12:24 a.m.
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - PR Newswire

Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis PR Newswire

Published: March 25, 2026, 12:08 a.m.
Bridging the gap: meta-epidemiological analysis on the clinical translation of stem cell-based therapies in women's reproductive diseases.

What is the current landscape of randomized controlled trials (RCTs) evaluating stem cell-based therapies for women's reproductive diseases, and how effectively has preclinical research informed their clinical translation?

Published: March 21, 2026, midnight
Endometrial Cancer Clinical Trial Pipeline Accelerates as 50+ - openPR.com

Endometrial Cancer Clinical Trial Pipeline Accelerates as 50+ openPR.com

Published: March 17, 2026, 11:40 p.m.
Efficacy of probiotic supplementation in reducing primary dysmenorrhea: a double-blinded randomized controlled trial.

Primary dysmenorrhea is painful menstruation in the absence of pelvic pathology, whereas secondary dysmenorrhea is menstrual pain attributable to an underlying pelvic disease (e.g., endometriosis). Nonsteroidal anti-inflammatory drugs (NSAIDs) are …

Published: March 17, 2026, midnight
Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie - Barchart.com

Endometriosis Pain Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma, Abbvie Barchart.com

Published: March 4, 2026, 1:30 p.m.
Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis - marketscreener.com

Ananda Pharma Receives MHRA And NHS Ethics Approval For Endocan Phase 2 Clinical Trial For Endometriosis marketscreener.com

Published: March 4, 2026, 11:51 a.m.
ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis - lelezard.com

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis lelezard.com

Published: March 4, 2026, 10:17 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!